In the headquarters of a mid-sized pharmaceutical company preparing for its first product launch, a scene once considered ...

Psychedelics like LSD and psilocybin (the active ingredient in magic mushrooms) are gaining increasing attention in ...

Vir Biotechnology (VIR) delivered earnings and revenue surprises of -6.02% and 84.51%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Now is the time for the biotechnology sector to ask for big changes to the FDA, NIH, reimbursement, intellectual property and ...

We have a responsibility to ensure that our discoveries are used in the public interest. That isn’t always easy.

The firm, a prolific backer of drug startups, will use the cash to back companies working on therapeutics, medical devices and healthcare services.

While major market indexes like the S&P 500 have struggled to gain traction in 2025 and remain in the red YTD, certain ...

At a conference in Washington, D.C., in 2000, the secretoglobin super family of proteins was named to classify proteins with ...

Bioheaven360 introduces AI-driven genomics diagnostic platform for early disease detection: Our Bureau, Bengaluru Thursday, May 8, 2025, 14:15 Hrs [IST] Bioheaven360 Genotec, a le ...

The professor’s 90-year-old father used to work at ONGC and the frauds siphoned off the money from his account after gaining ...